Compare Eli Lilly And Co (LLY) vs VICI Properties Inc (VICI) Price & Performance

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

VICI Properties trades at $25.99, down 0.33% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed Q2 2026 earnings with an EPS miss but revenue beat, while maintaining strong profitability margins near 67%. Recent news highlights a $1.75 billion notes offering and positive dividend coverage, with analysts largely bullish.

Outlook remains positive given a 6.6% dividend yield, low P/E of 10.07, and consensus price target of $29.83 implying 15% upside. Risks include earnings volatility, high leverage with $843.61M interest expense, and macroeconomic sensitivity affecting real estate valuations.